Search

Board Moves May 31, 2017

Dr Simon Buckingham will step down as non-executive director of Creso Pharma and take on a consulting role, assisting newly appointed chief operating officer David Russell with the development of commercial plans and strategic partnerships. 

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLPC cresa

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/08/18

1 year TSR5 year TSR
184thGalaxy Resources44%42%
272ndMillennium Minerals24%-13%
530thTroy Resources-15%-42%
729thAlkane Resources-50%-11%
737 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

08/12/16
$228k Sold
07/12/16
$41k Sold
23/11/16
$122k Sold
Total value as at the date of the transaction
Source: Morningstar

Revenue

29th↑Alkane Resources$130.3m
30th↑Galaxy Resources$128.1m
31st↑Troy Resources$116.5m
32nd↓Millennium Minerals$116.0m
33rd↓Tiger Resources$113.2m
507 listed resources companies ranked by revenue.
Source: Morningstar

Remuneration from Troy Resources

127thKen Nilsson$641k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer